Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
Quick Stats
Jul 14, 202648.2
AI Score
HOLD1.98
Volume Ratio
Aug 05, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
TARS Stock Summary
Last updated Jul 14, 2026
TARS is currently trading at $56.11, positioned below its 200-day moving average of $69.02, suggesting bearish momentum. The stock has a 52-week range of $38.51 to $85.25.
Technical Analysis: The 50-day moving average stands at $62.35, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 38.643, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.093, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TARS at 48.2/100 with a HOLD recommendation.
TARS (Tarsus Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Jul 14, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 38.643 |
| CMF (20) | -0.093 |
| ROC (10) | -8.407 |
| ADX (14) | 17.596 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.529 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -96.582 |
| MFI (14) | 33.425 |
TARS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TARS Price vs Max Options Open Interest
TARS Max Change In Options Open Interest
TARS Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TARS Daily Out of Money Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TARS Daily In the Money Options - Sort by Max open Interest (near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TARS Most Active Options by Volume(near term)
14th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Tarsus Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
TARS Moving Averages Analysis
TARS (Tarsus Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jul 14, 2026
| Days | MA |
|---|---|
| 10 | 63.23 |
| 20 | 63.3 |
| 30 | 62.26 |
| 50 | 62.35 |
| 100 | 65.66 |
| 200 | 69.02 |
TARS Fundamental Analysis
| P/E (Forward) | 106.383 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.6 billion |
| Earnings/Share ($) | -1.11 |
| Net Proft Margin (%) | -0.0902 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.04 |
| EPS Estimate Next Year ($) | 2.7 |
| WallStreet Target Price ($) | 94.25 |
| Most Recent Quarter |